v2.4.0.6
Condensed Consolidated Statements of Operations (USD $)
 3 Months Ended 9 Months Ended
Sep. 30, 2012
Sep. 30, 2011
Sep. 30, 2012
Sep. 30, 2011
Income Statement [Abstract]        
Sales $ 3,525,933 $ 4,029,590 $ 10,837,425 $ 12,617,710
Cost of sales 2,672,448 3,220,450 8,491,880 10,147,624
Gross profit 853,485 809,140 2,345,545 2,470,086
Operating expenses        
Salaries and related expenses 755,201 680,852 2,237,510 2,021,761
Selling, general and administrative 680,888 610,864 2,179,991 1,360,795
Total operating expenses 1,436,089 1,291,716 4,417,501 3,382,556
Loss from operations before non-controlling interest (582,604) (482,576) (2,071,956) (912,470)
Other expenses        
Interest expense, net 347,771 303,439 1,086,950 626,708
Loss on extinguishment of debt 90,205    90,205 16,923
(Gain) or loss on change in fair value of warrant liability 377,430 (139,355) 275,350 (106,231)
Total other expenses and income 815,406 164,084 1,452,505 537,400
Net loss from operations before non-controlling interest (1,398,010) (646,660) (3,524,461) (1,449,870)
Net income attributable to non-controlling interest          (12,051)
Net loss attributable to Assured Pharmacy, Inc. $ (1,398,010) $ (646,660) $ (3,524,461) $ (1,461,921)
Basic and diluted loss per common share        
Net loss per common share - basic and diluted $ (0.33) $ (0.20) $ (0.86) $ (0.55)
Basic and diluted weighted average number of common shares outstanding 4,298,150 3,203,346 4,077,600 2,657,202